lutetium lu 177 vipivotide tetraxetan,cabazitaxel,docetaxel
emcure,sanofi,novartis,aventis
['gucsm', 'pcsm', 'therap ', 'crpc', 'cabazitaxel', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'prostate', 'docetaxel']
lu-177 vipivotide tetraxetan yields similar os vs cabazitaxel in mcrpc progressing after docetaxel. #therap #ascodailynews #asco22 #gucsm #prostatecancer #pcsm
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ? endorse.